Pharmaceuticals and economic evaluation

16.05.2013 - Uncategorized

With increased capacity, Oslo Economics has been able to assist an increasing number of pharmaceutical/device companies. We support gathering of cost data, undertake modelling and prepare reimbursement applications.

We also offer strategic assessment and handle public affairs related to pharmaceutics and devices.

For more information, contact Ivar Sønbø Kristiansen/Erik Magnus Sæther.

Alternative clinical endpoints: The path to better treatment?

On November 27, Oslo Economics and Bristol Myers Squibb are hosting a breakfast meeting on the healthcare system’s structure and its ability to prioritize in today’s rapidly evolving technological landscape.
Join us to hear presentations from a range of engaging speakers and participate in the discussion.

Oslo Economics assigned with exploring the future of coastal shipping in Norway

Oslo Economics has been commissioned by the Ministry of Transport to explore various aspects of the coastal route operation between Bergen and Kirkenes. In this context, we will examine transportation needs for passengers and freight, environmental impacts, and the potential for tightening environmental requirements.

Pharmaceuticals and economic evaluation

Alternative clinical endpoints: The path to better treatment?

Oslo Economics assigned with exploring the future of coastal shipping in Norway

Oslo Economics celebrates its 15 year anniversary!

Bergen

Oslo

Berlin